Bids submitted by Anchor Investors will be submitted and allocated one Working Day prior to the Bid/Issue Opening Date, being September 18, 2020.
The Company is a leading manufacturer of speciality chemicals such as Hexamethyldisilazane (HMDS) and Chloromethyl Isopropyl Carbonate (CMIC) which are chemicals predominately used in the pharmaceutical industry. It manufactures Inorganic Bromides used as completion fluids in the oilfield industry.
- Minimum Bid Lot is 44 Equity Shares and in multiples of 44 Equity Shares thereafter
- Price Band of ₹ 338 – ₹ 340 per Equity Share
- Issue Opening Date – September 21, 2020* and Issue Closing Date – September 23, 2020
- The Floor Price is 33.8 times the Face Value of the Equity Shares and the Cap Price is 34 times the Face Value of the Equity Shares
The Issue is being made through the book building process in accordance with Regulation 6(1) of the Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations, 2018, as amended, where allocation to QIBs is not more than 50% of the Issue size, Non-Institutional Bidders is not less than 15% of the Issue size and Retail Individual Bidders is not less than 35% of the Issue size.
The Company intends to utilize the Net Proceeds from the Fresh Issue towards capital expenditure towards expansion of the Manufacturing Facility, To meet working capital requirements and towards general corporate purposes.
Intensive Fiscal Services Private Limited and Ambit Capital Private Limited are the BRLMs to the Issue.